Structure-guided discovery of a single-domain antibody agonist against human apelin receptor

Journal: Science Advances

Published: 2020-01-01

DOI: 10.1126/sciadv.aax7379

Affiliations: 2

Authors: 13

Go to article
Institutions Share
Amgen Biopharmaceutical RD (Shanghai) Company, Limited, China 0.92
Amgen Inc., United States of America (USA) 0.08

Return